(Health-NewsWire.Net, May 20, 2016 ) Bones have the ability to grow and heal naturally, but changes in diet, exercise levels, and body chemistry lead to changes in the bone mineral density. This results in osteoporosis, which is characterized by low bone density and structural deterioration of bone tissues, leading to fragile bones. Rapid bone resorption or slow bone replacement can result in the development of the disease. Gender, age, body size (low body weight), ethnicity, and family history also play a role in developing osteoporosis. Other risk factors include medication, calcium and vitamin intake, alcohol intake, and smoking. Women are at a greater risk of developing osteoporosis than men as estrogens play an important role in maintaining bone strength. Small amounts of bone are lost as part of normal aging process, but on reaching menopause, estrogen levels decline drastically, leading to a greater risk of developing osteoporosis.
Technavios analysts forecast the Global Postmenopausal Osteoporosis Drugs Market to grow at a CAGR of 4.02% during the period 2016-2020.
To Get Sample Copy of Report visit @ http://www.researchmoz.us/enquiry.php?type=S&repid=720156
Covered in this report The report covers the present scenario and the growth prospects of the Global Postmenopausal Osteoporosis Drugs Market for 2016-2020. To calculate the market size, the report considers revenue generated from the sales of branded and generic drugs used to treat and prevent postmenopausal osteoporosis.
The market is divided into the following segments based on geography: Americas APAC EMEA
New report, Global Postmenopausal Osteoporosis Drugs Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
Browse Detail Report With TOC @ http://www.researchmoz.us/global-postmenopausal-osteoporosis-drugs-market-2016-2020-report.html
Key vendors Eli Lilly Amgen Merck Novartis
Other prominent vendors Allergan Amgen Astellas Biopharm Deltanoid Pharmaceuticals Noven Novo Nordisk Osteologix Pfizer PhytoHealth Radius Health Tarsa Therapeutics UCB Uni-Bio Science Group Upsher-Smith Laboratories Watson Pharmaceuticals Zosano Pharma
Market driver Growing prevalence of postmenopausal osteoporosis For a full, detailed list, view our report
Market challenge Low diagnosis rate For a full, detailed list, view our report
Market trend Emergence of novel agents For a full, detailed list, view our report
Key questions answered in this report What will the market size be in 2020 and what will the growth rate be? What are the key market trends? What is driving this market? What are the challenges to market growth? Who are the key vendors in this market space? What are the market opportunities and threats faced by the key vendors? What are the strengths and weaknesses of the key vendors?
For Market Research Latest Reports Visit @ http://www.researchmoz.us/latest-report.html
About ResearchMoz
ResearchMoz is the one stop online destination to find and buy market research reports & Industry Analysis. We fulfill all your research needs spanning across industry verticals with our huge collection of market research reports. We provide our services to all sizes of organizations and across all industry verticals and markets. Our Research Coordinators have in-depth knowledge of reports as well as publishers and will assist you in making an informed decision by giving you unbiased and deep insights on which reports will satisfy your needs at the best price.
For More Information Kindly Contact:
ResearchMoz Mr. Nachiket Ghumare, Tel: +1-518-621-2074 USA-Canada Toll Free: 866-997-4948 Email: sales@researchmoz.us
Browse Our Latest Press Releases @ http://www.researchmoz.us/pressrelease
Researchmoz Global Pvt.Ltd
Researchmoz
+1-518-621-2074
sales@researchmoz.us
Source: EmailWire.Com
|